[1] Ott JJ, Stevens GA, Groeger J,et al. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine,2012,30:2212-2219.
[2] Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet, 2015,386:1546-1555.
[3] European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol, 2017, 67:370-398.
[4] 中华医学会肝病学分会,中华医学会感染与寄生虫病学分会.慢性乙型肝炎防治指南 (2015年版).中国肝脏病杂志(电子版),2015,7:1-18.
[5] Mason WS, Gill US, Litwin S, et al. HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant. Gastroenterology,2016,151:986-998.
[6] Kennedy PTF, Sandalova E, Jo J, et al. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology, 2012,143:637-645.
[7] Bertoletti A, Ferrari C. Adaptive immunity in HBV infection. J Hepatol, 2016,64:S71-S83.
[8] Huang JM, Huang TH,Qiu HY, et al. Effects of hepatitis B virus infection on human sperm chromosomes.World J Gastroenterol,2003,9:736-740.
[9] Papatheodoridis GV. Hepatitis B virus treatment: which patients can have treatment deferred? Clin Liver Dis,2013,2:15-17.
[10] Kumar M,Sarin SK,Hissar S,et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.Gastroenterology,2008,134: 1376-1384.
[11] Wong GL, Chan HL, Yu Z, et al. Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: a prospective cohort study with paired transient elastography examination. J Gastroenterol Hepatol,2013,28:1762-1769. |
